Tsao David sold $929K of BLLN

Tsao David (Chief Technology Officer) sold 10,000 shares of BillionToOne, Inc. (BLLN) at $92.86 ($0.93M total) on 2026-08-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Tsao David
Published Aug 12, 2026, 10:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 11:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BLLN
Neutral
high confidence
Mentioned
$BLLN
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLLNNeutralLow
01

Why it matters

The newest fact is the specific sale size (10,000 shares), price ($92.86), and that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 framing makes it less actionable as a fundamental catalyst.

03

What to watch

The filing does not indicate intent beyond the plan; without context on total holdings, prior sales cadence, or option exercises, the signal is weak.

Relevance 4/10Novelty 3/10Timing: filed after-hours on 2026-08-12, covering a sale dated 2026-08-10

Background

The article is an SEC Form 4 insider transaction disclosure for BillionToOne, Inc. (BLLN).

Company-level read

Ticker impact

$BLLNNeutralHigh confidence
Context

BillionToOne CTO David Tsao sold 10,000 shares at $92.86 on 2026-08-10 under a pre-arranged 10b5-1 plan, per Form 4.

Expected impact

Likely minimal near-term impact; any reaction would be sentiment-driven rather than fundamental.

Evidence & confidence

Form 4 shows an open-market sale, but the filing states a pre-arranged 10b5-1 plan, which typically reduces interpretability as a new negative view.

Market effects

No clear sector read-through from a single 10b5-1 insider sale disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales can still coincide with private information, and the market may overreact even when a 10b5-1 plan is cited.

Key entities

  • BillionToOne, Inc.

    Company whose insider transaction is disclosed on Form 4.

  • Tsao David

    Chief Technology Officer and officer/director who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Why is BillionToOne stock sliding today?

BillionToOne stock fell 6.2% in pre-market trading after Fuzzy Panda Research disclosed a short position and alleged regulatory and billing misconduct, including overbilling and potential unlawful practices. The company's stock had already declined from its 52-week high of $150.44, and broader market pressures contributed to the decline.

$BLLNMed

BillionToOne shares slide in pre-market trading following short-seller report

BillionToOne (BLLN) shares fell 6% premarket after a short-seller report alleged improper billing, undisclosed regulatory scrutiny, and clinical claim weaknesses. Fuzzy Panda Research, which holds a short position, cited FOIA records, anonymous sources, and billing data. The report claims potential EBITDA reduction of 80% and False Claims Act penalties up to $1.2B. BillionToOne has not responded.

$BLLNMed

BillionToOne: Q3 Earnings Snapshot

BillionToOne (BLLN) reported Q3 earnings of $17.4M, or 32 cents per share, beating estimates of 16 cents. Revenue was $123M, exceeding forecasts of $116.2M. The company expects full-year revenue between $460M and $470M. Shares have risen 39% YTD.